APO RESEARCH · REPORT
Levonorgestrel API
Levonorgestrel is a hormonal medication which is used in a number of birth control methods.
Product & engineering
Understand the product.
Levonorgestrel is a hormonal medication which is used in a number of birth control methods.
Selected research
Industry Research
Levonorgestrel API Industry Research Report 2026
Market perspective
Levonorgestrel is a hormonal medication which is used in a number of birth control methods.
By type, the Global Levonorgestrel API market share is the highest in the short-acting contraceptive API, about 67.17%. The most proportion of the Global Levonorgestrel API market share is used for Levonorgestrel Tablet and the proportion is about 52.74% in 2020.
Report Scope
Read the full market overview
This report quantifies the global Levonorgestrel API market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Levonorgestrel API Market by Company
Bayer HealthCare
Qinhuangdao Zizhu Pharmaceutical
Yangzhou Pharmaceutical
Lupin
Hubei Gedian Humanwell
Sterling Spa
Formos
Huazhong Pharm
ASG Biochem
Levonorgestrel API Segment by Type
Short-Acting Contraceptive API
Long-Acting Contraceptive API
Levonorgestrel API Segment by Application
Levonorgestrel Tablet
Mixture Products
Hormone-releasing IUD
Levonorgestrel API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Levonorgestrel API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Levonorgestrel API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Levonorgestrel API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Levonorgestrel API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Levonorgestrel API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Levonorgestrel API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Short-Acting Contraceptive API
- Long-Acting Contraceptive API
Applications
- Levonorgestrel Tablet
- Mixture Products
- Hormone-releasing IUD
Companies covered
- Bayer HealthCare
- Qinhuangdao Zizhu Pharmaceutical
- Yangzhou Pharmaceutical
- Lupin
- Hubei Gedian Humanwell
- Sterling Spa
- Formos
- Huazhong Pharm
- ASG Biochem
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Levonorgestrel API Market Size (2021-2032)
- 2.2.2 Global Levonorgestrel API Sales (2021-2032)
- 2.2.3 Global Levonorgestrel API Market Average Price (2021-2032)
- 2.3 Levonorgestrel API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Short-Acting Contraceptive API
- 2.3.3 Long-Acting Contraceptive API
- 2.4 Levonorgestrel API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Levonorgestrel Tablet
- 2.4.3 Mixture Products
- 2.4.4 Hormone-releasing IUD
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Levonorgestrel API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Levonorgestrel API Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Levonorgestrel API Revenue of Manufacturers (2021-2026)
- 3.4 Global Levonorgestrel API Average Price by Manufacturers (2021-2026)
- 3.5 Global Levonorgestrel API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Levonorgestrel API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Levonorgestrel API, Product Type & Application
- 3.8 Global Manufacturers of Levonorgestrel API, Established Date
- 3.9 Global Levonorgestrel API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bayer HealthCare
- 4.1.1 Bayer HealthCare Company Information
- 4.1.2 Bayer HealthCare Business Overview
- 4.1.3 Bayer HealthCare Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bayer HealthCare Levonorgestrel API Product Portfolio
- 4.1.5 Bayer HealthCare Recent Developments
- 4.2 Qinhuangdao Zizhu Pharmaceutical
- 4.2.1 Qinhuangdao Zizhu Pharmaceutical Company Information
- 4.2.2 Qinhuangdao Zizhu Pharmaceutical Business Overview
- 4.2.3 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product Portfolio
- 4.2.5 Qinhuangdao Zizhu Pharmaceutical Recent Developments
- 4.3 Yangzhou Pharmaceutical
- 4.3.1 Yangzhou Pharmaceutical Company Information
- 4.3.2 Yangzhou Pharmaceutical Business Overview
- 4.3.3 Yangzhou Pharmaceutical Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Yangzhou Pharmaceutical Levonorgestrel API Product Portfolio
- 4.3.5 Yangzhou Pharmaceutical Recent Developments
- 4.4 Lupin
- 4.4.1 Lupin Company Information
- 4.4.2 Lupin Business Overview
- 4.4.3 Lupin Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Lupin Levonorgestrel API Product Portfolio
- 4.4.5 Lupin Recent Developments
- 4.5 Hubei Gedian Humanwell
- 4.5.1 Hubei Gedian Humanwell Company Information
- 4.5.2 Hubei Gedian Humanwell Business Overview
- 4.5.3 Hubei Gedian Humanwell Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hubei Gedian Humanwell Levonorgestrel API Product Portfolio
- 4.5.5 Hubei Gedian Humanwell Recent Developments
- 4.6 Sterling Spa
- 4.6.1 Sterling Spa Company Information
- 4.6.2 Sterling Spa Business Overview
- 4.6.3 Sterling Spa Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sterling Spa Levonorgestrel API Product Portfolio
- 4.6.5 Sterling Spa Recent Developments
- 4.7 Formos
- 4.7.1 Formos Company Information
- 4.7.2 Formos Business Overview
- 4.7.3 Formos Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Formos Levonorgestrel API Product Portfolio
- 4.7.5 Formos Recent Developments
- 4.8 Huazhong Pharm
- 4.8.1 Huazhong Pharm Company Information
- 4.8.2 Huazhong Pharm Business Overview
- 4.8.3 Huazhong Pharm Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Huazhong Pharm Levonorgestrel API Product Portfolio
- 4.8.5 Huazhong Pharm Recent Developments
- 4.9 ASG Biochem
- 4.9.1 ASG Biochem Company Information
- 4.9.2 ASG Biochem Business Overview
- 4.9.3 ASG Biochem Levonorgestrel API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 ASG Biochem Levonorgestrel API Product Portfolio
- 4.9.5 ASG Biochem Recent Developments
5 Global Levonorgestrel API Market Scenario by Region
- 5.1 Global Levonorgestrel API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Levonorgestrel API Sales by Region: 2021-2032
- 5.2.1 Global Levonorgestrel API Sales by Region: 2021-2026
- 5.2.2 Global Levonorgestrel API Sales by Region: 2027-2032
- 5.3 Global Levonorgestrel API Revenue by Region: 2021-2032
- 5.3.1 Global Levonorgestrel API Revenue by Region: 2021-2026
- 5.3.2 Global Levonorgestrel API Revenue by Region: 2027-2032
- 5.4 North America Levonorgestrel API Market Facts & Figures by Country
- 5.4.1 North America Levonorgestrel API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Levonorgestrel API Sales by Country (2021-2032)
- 5.4.3 North America Levonorgestrel API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Levonorgestrel API Market Facts & Figures by Country
- 5.5.1 Europe Levonorgestrel API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Levonorgestrel API Sales by Country (2021-2032)
- 5.5.3 Europe Levonorgestrel API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Levonorgestrel API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Levonorgestrel API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Levonorgestrel API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Levonorgestrel API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Levonorgestrel API Market Facts & Figures by Country
- 5.7.1 South America Levonorgestrel API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Levonorgestrel API Sales by Country (2021-2032)
- 5.7.3 South America Levonorgestrel API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Levonorgestrel API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Levonorgestrel API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Levonorgestrel API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Levonorgestrel API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Levonorgestrel API Sales by Type (2021-2032)
- 6.1.1 Global Levonorgestrel API Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Levonorgestrel API Sales Market Share by Type (2021-2032)
- 6.2 Global Levonorgestrel API Revenue by Type (2021-2032)
- 6.2.1 Global Levonorgestrel API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Levonorgestrel API Revenue Market Share by Type (2021-2032)
- 6.3 Global Levonorgestrel API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Levonorgestrel API Sales by Application (2021-2032)
- 7.1.1 Global Levonorgestrel API Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Levonorgestrel API Sales Market Share by Application (2021-2032)
- 7.2 Global Levonorgestrel API Revenue by Application (2021-2032)
- 7.2.1 Global Levonorgestrel API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Levonorgestrel API Revenue Market Share by Application (2021-2032)
- 7.3 Global Levonorgestrel API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Levonorgestrel API Value Chain Analysis
- 8.1.1 Levonorgestrel API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Levonorgestrel API Production Mode & Process
- 8.2 Levonorgestrel API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Levonorgestrel API Distributors
- 8.2.3 Levonorgestrel API Customers
9 Global Levonorgestrel API Analyzing Market Dynamics
- 9.1 Levonorgestrel API Industry Trends
- 9.2 Levonorgestrel API Industry Drivers
- 9.3 Levonorgestrel API Industry Opportunities and Challenges
- 9.4 Levonorgestrel API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst